Suven Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2025 ,inter alia, to consider and approve Un-audited Financial Results ....
SUVEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Suven Life Sciences has informed exchanges that its Board of Directors will meet on Tuesday, November 11, 2025, at its Hyderabad registered office. The main agenda is to consider and approve the Un-audited Standalone and Consolidated Financial Results for the quarter and half-year ended September 30, 2025. The trading window for designated persons and their relatives has been closed since October 1, 2025 and will remain closed until 48 hours after the results are declared. No actual financial numbers have been disclosed in this filing — it is purely a procedural intimation required under SEBI LODR Regulations.
This is a routine pre-results announcement, so no immediate stock price impact is expected from this filing itself. Investors should watch November 11, 2025 for the actual Q2/H1 FY26 numbers, which will be the next catalyst for the stock.